Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 37 items for :

  • incretin-based therapy x
Clear All
Lili Liu Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Lili Liu in
Google Scholar
PubMed Close
,
Zhuo Shao Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, Shanghai, China

Search for other papers by Zhuo Shao in
Google Scholar
PubMed Close
,
Ying Xia Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Ying Xia in
Google Scholar
PubMed Close
,
Jiabi Qin Department of Epidemiology & Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China

Search for other papers by Jiabi Qin in
Google Scholar
PubMed Close
,
Yang Xiao Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Yang Xiao in
Google Scholar
PubMed Close
,
Zhiguang Zhou Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Zhiguang Zhou in
Google Scholar
PubMed Close
, and
Zubing Mei Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Search for other papers by Zubing Mei in
Google Scholar
PubMed Close

influence of incretin-based therapy added to insulin vs placebo or no drug added to insulin in subjects with type 1 diabetes on the key outcomes HbA1c, total insulin dose, body weight, severe hypoglycaemia and gastrointestinal side effects. Methods

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0546
Volume/Issue:
Volume 8: Issue 3
Open access
Svjatoslavs Kistkins Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed Close
,
Othmar Moser Division of Exercise Physiology and Metabolism, Institute of Sport Science, University of Bayreuth, Bayreuth, Germany

Search for other papers by Othmar Moser in
Google Scholar
PubMed Close
,
Vitālijs Ankudovičs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed Close
,
Dmitrijs Blizņuks Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed Close
,
Timurs Mihailovs Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed Close
,
Sergejs Lobanovs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed Close
,
Harald Sourij Trials Unit for Interdisciplinary Metabolic Medicine, Division of Endocrinology and Diabetolgoy, Medical University of Graz, Graz, Austria

Search for other papers by Harald Sourij in
Google Scholar
PubMed Close
,
Andreas F H Pfeiffer Department of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Hindenburgdamm, Berlin, Germany

Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed Close
, and
Valdis Pīrāgs Pauls Stradiņš Clinical University Hospital, Riga, Latvia
Faculty of Medicine, University of Latvia, Riga, Latvia

Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed Close

perspectives in the combinatory use of incretin-based therapies in diabesity and physiological nature of hormonal crosstalk The primary objective of treating diabetes in particular novel pharmacological options leading to significant weight loss is to enhance

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0529
Volume/Issue:
Volume 13: Issue 5
Open access
David S Mathiesen Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by David S Mathiesen in
Google Scholar
PubMed Close
,
Jonatan I Bagger Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed Close
,
Katrine B Hansen Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark

Search for other papers by Katrine B Hansen in
Google Scholar
PubMed Close
,
Anders E Junker Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Anders E Junker in
Google Scholar
PubMed Close
,
Astrid Plamboeck Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Astrid Plamboeck in
Google Scholar
PubMed Close
,
Signe Harring Department of Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark

Search for other papers by Signe Harring in
Google Scholar
PubMed Close
,
Thomas Idorn Center for Cancer and Organ Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Thomas Idorn in
Google Scholar
PubMed Close
,
Mads Hornum Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Cancer and Organ Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Mads Hornum in
Google Scholar
PubMed Close
,
Jens J Holst Novartis Healthcare A/S, Copenhagen, Denmark

Search for other papers by Jens J Holst in
Google Scholar
PubMed Close
,
Anna E Jonsson Novartis Healthcare A/S, Copenhagen, Denmark

Search for other papers by Anna E Jonsson in
Google Scholar
PubMed Close
,
Torben Hansen Novartis Healthcare A/S, Copenhagen, Denmark

Search for other papers by Torben Hansen in
Google Scholar
PubMed Close
,
Tina Vilsbøll Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Novartis Healthcare A/S, Copenhagen, Denmark
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close
,
Asger Lund Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Asger Lund in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Medicine, Gentofte and Herlev Hospital, University of Copenhagen, Denmark
Novartis Healthcare A/S, Copenhagen, Denmark
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

to incretin-based treatments. Another strength of our study is the sample size of 104 individuals characterized by the OGTT and IIGI method, which is the largest cohort used to evaluate the impact of TCF7L2 genotype on the action of endogenous

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0471
Volume/Issue:
Volume 9: Issue 12
Open access
Agnieszka Kosowska Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Agnieszka Kosowska in
Google Scholar
PubMed Close
,
Enrique Gallego-Colon Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Enrique Gallego-Colon in
Google Scholar
PubMed Close
,
Wojciech Garczorz Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Wojciech Garczorz in
Google Scholar
PubMed Close
,
Agnieszka Kłych-Ratuszny Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Agnieszka Kłych-Ratuszny in
Google Scholar
PubMed Close
,
Mohammad Reza F Aghdam Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Mohammad Reza F Aghdam in
Google Scholar
PubMed Close
,
Michał Woz´niak Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Michał Woz´niak in
Google Scholar
PubMed Close
,
Andrzej Witek Department of Gynaecology and Obstetrics, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Andrzej Witek in
Google Scholar
PubMed Close
,
Agnieszka Wróblewska-Czech Department of Gynaecology and Obstetrics, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Agnieszka Wróblewska-Czech in
Google Scholar
PubMed Close
,
Anna Cygal Department of Gynaecology and Obstetrics, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Anna Cygal in
Google Scholar
PubMed Close
,
Jerzy Wojnar Department of Internal Medicine and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Jerzy Wojnar in
Google Scholar
PubMed Close
, and
Tomasz Francuz Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Search for other papers by Tomasz Francuz in
Google Scholar
PubMed Close

of cancer, especially pancreatic cancer, in patients on incretin therapies ( 25 ). However, randomized clinical trials showed that incretin-based drugs were not associated with an increased risk of pancreatic cancer ( 26 ). Overall, the scarce in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0294
Volume/Issue:
Volume 6: Issue 8
Open access
L Ahlkvist
Search for other papers by L Ahlkvist in
Google Scholar
PubMed Close
,
K Brown Department of Clinical Sciences, GlaxoSmithKline, Biomedical Center, C11, Lund University, SE 22184 Lund, Sweden

Search for other papers by K Brown in
Google Scholar
PubMed Close
, and
B Ahrén
Search for other papers by B Ahrén in
Google Scholar
PubMed Close

glucose challenge in association with reduced insulin secretion. This is the base for the success of incretin therapy in type 2 diabetes (22) . In insulin-resistant mice, we have previously demonstrated that the β-cell response to intravenous GLP1 is

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-12-0079
Volume/Issue:
Volume 2: Issue 2
Open access
Jothydev Kesavadev Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Jothydev Kesavadev in
Google Scholar
PubMed Close
,
Pradeep Babu Sadasivan Pillai Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Pradeep Babu Sadasivan Pillai in
Google Scholar
PubMed Close
,
Arun Shankar Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Arun Shankar in
Google Scholar
PubMed Close
,
Gopika Krishnan Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Gopika Krishnan in
Google Scholar
PubMed Close
, and
Sunitha Jothydev Jothydev’s Diabetes Research Centre, Trivandrum, Kerala, India

Search for other papers by Sunitha Jothydev in
Google Scholar
PubMed Close

440 T2DM patients with inadequate glycemic control. The incretin-based therapies like GLP-1 agonists and DPP-4 inhibitors are being reported to be particularly effective in Asian patients with T2DM ( 25 ). This could be due to genetic factors, possibly

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0100
Volume/Issue:
Volume 6: Issue 8
Open access
Henri Honka Turku PET Centre, University of Turku, Turku, Finland

Search for other papers by Henri Honka in
Google Scholar
PubMed Close
,
Jukka Koffert Turku PET Centre, University of Turku, Turku, Finland
Department of Gastroenterology, Turku University Hospital, Turku, Finland

Search for other papers by Jukka Koffert in
Google Scholar
PubMed Close
,
Saila Kauhanen Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland

Search for other papers by Saila Kauhanen in
Google Scholar
PubMed Close
,
Nobuyuki Kudomi Faculty of Medicine, Kagawa University, Kagawa, Japan

Search for other papers by Nobuyuki Kudomi in
Google Scholar
PubMed Close
,
Saija Hurme Department of Biostatistics, University of Turku, Turku, Finland

Search for other papers by Saija Hurme in
Google Scholar
PubMed Close
,
Andrea Mari Institute of Neuroscience, National Research Council, Padua, Italy

Search for other papers by Andrea Mari in
Google Scholar
PubMed Close
,
Andreas Lindqvist Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed Close
,
Nils Wierup Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Nils Wierup in
Google Scholar
PubMed Close
,
Riitta Parkkola Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland

Search for other papers by Riitta Parkkola in
Google Scholar
PubMed Close
,
Leif Groop Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Leif Groop in
Google Scholar
PubMed Close
, and
Pirjo Nuutila Turku PET Centre, University of Turku, Turku, Finland
Department of Endocrinology, Turku University Hospital, Turku, Finland

Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed Close

. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects . Regulatory Peptides 2003 114 115 – 121 . ( https://doi.org/10.1016/S0167

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0234
Volume/Issue:
Volume 7: Issue 7
Open access
Giuseppe Lisco Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed Close
,
Anna De Tullio Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Anna De Tullio in
Google Scholar
PubMed Close
,
Olga Disoteo Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Search for other papers by Olga Disoteo in
Google Scholar
PubMed Close
,
Giuseppina Piazzolla Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed Close
,
Edoardo Guastamacchia Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed Close
,
Carlo Sabbà Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Carlo Sabbà in
Google Scholar
PubMed Close
,
Vincenzo De Geronimo Unit of Endocrinology, Policlinico Morgagni CCD, Catania, Italy

Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed Close
,
Enrico Papini Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed Close
, and
Vincenzo Triggiani Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed Close

verify it by stratifying the analyses and reassessing the risks based on the presence (or absence) of GLP-1 receptors on thyroid samples. Conclusion Further studies are urgently needed to provide more evidence on the role played by the incretin

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0257
Volume/Issue:
Volume 12: Issue 11
Open access
Melinda Kertész Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Melinda Kertész in
Google Scholar
PubMed Close
,
Szilárd Kun Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Szilárd Kun in
Google Scholar
PubMed Close
,
Eszter Sélley Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Eszter Sélley in
Google Scholar
PubMed Close
,
Zsuzsanna Nagy Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed Close
,
Tamás Kőszegi Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed Close
, and
István Wittmann Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by István Wittmann in
Google Scholar
PubMed Close

(mmHg) 77 ± 9  Heart rate (b.p.m) 75 ± 10 Drug therapy  Antihypertensives   ACE inhibitors (%) 14 (67)   Calcium channel blockers (%) 9 (43)   Diuretics (%) 7 (33)  Statin (%) 6 (29

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0218
Volume/Issue:
Volume 10: Issue 7
Open access
Giovanni Fanni Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Giovanni Fanni in
Google Scholar
PubMed Close
,
Petros Katsogiannos Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed Close
,
Bipasha Nandi Jui Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed Close
,
Magnus Sundbom Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Magnus Sundbom in
Google Scholar
PubMed Close
,
Susanne Hetty Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Susanne Hetty in
Google Scholar
PubMed Close
,
Maria J Pereira Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Maria J Pereira in
Google Scholar
PubMed Close
, and
Jan W Eriksson Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Jan W Eriksson in
Google Scholar
PubMed Close

metabolic shift is partly independent of weight loss, and the underlying mechanisms are not completely understood ( 3 , 4 , 5 , 6 ). Shortly after RYGB, a greater incretin response occurs post-prandially, which enhances insulin secretion, reduces food

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0172
Volume/Issue:
Volume 11: Issue 8
Open access